Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.

Eric M. Reiman; Guy M. McKhann; Marilyn S. Albert; Reisa A. Sperling; Ronald C. Petersen; Deborah Blacker

doi:10.4088/jcp.10087tx2c

Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.

Eric M. Reiman, Guy M. McKhann, Marilyn S. Albert, Reisa A. Sperling, Ronald C. Petersen, Deborah Blacker

Research output: Contribution to journal › Comment/debate

16 Scopus citations

Abstract

Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.

Original language	English
Pages (from-to)	e37
Journal	Journal of Clinical Psychiatry
Volume	72
Issue number	12
DOIs	https://doi.org/10.4088/jcp.10087tx2c
State	Published - Dec 2011
Externally published	Yes

Access to Document

10.4088/jcp.10087tx2c

Cite this

@article{f32437da7d894d468e9a8fe859ff7f97,

title = "Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.",

abstract = "Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.",

author = "Reiman, {Eric M.} and McKhann, {Guy M.} and Albert, {Marilyn S.} and Sperling, {Reisa A.} and Petersen, {Ronald C.} and Deborah Blacker",

year = "2011",

month = dec,

doi = "10.4088/jcp.10087tx2c",

language = "English",

volume = "72",

pages = "e37",

journal = "Journal of Clinical Psychiatry",

issn = "0160-6689",

publisher = "Physicians Postgraduate Press Inc.",

number = "12",

}

TY - JOUR

T1 - Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.

AU - Reiman, Eric M.

AU - McKhann, Guy M.

AU - Albert, Marilyn S.

AU - Sperling, Reisa A.

AU - Petersen, Ronald C.

AU - Blacker, Deborah

PY - 2011/12

Y1 - 2011/12

N2 - Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.

AB - Almost 30 years ago, the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease and Related Disorders Association (more commonly known as the Alzheimer's Association) developed the original clinical diagnostic criteria for Alzheimer's disease (AD). Recently, the National Institute on Aging and the Alzheimer's Association released updated research and diagnostic criteria for AD. The new criteria establish that AD exists on a continuum and is comprised of not only dementia but also a preclinical phase and a phase of mild cognitive impairment due to AD. The new criteria also describe advancements in biomarker evidence, which is still being researched and is not yet ready for clinical settings. Additionally, the American Psychiatric Association is currently revising the Diagnostic and Statistical Manual of Mental Disorders, which will include updated diagnostic criteria for AD and other neurocognitive disorders.

UR - http://www.scopus.com/inward/record.url?scp=84872466223&partnerID=8YFLogxK

U2 - 10.4088/jcp.10087tx2c

DO - 10.4088/jcp.10087tx2c

M3 - Comment/debate

C2 - 22244033

AN - SCOPUS:84872466223

SN - 0160-6689

VL - 72

SP - e37

JO - Journal of Clinical Psychiatry

JF - Journal of Clinical Psychiatry

IS - 12

ER -

Clinical impact of updated diagnostic and research criteria for Alzheimer's disease.

Abstract

Access to Document

Fingerprint

Cite this